ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 704171 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 704171; 2) Community: the network communities that were significantly associated with the response to NSC 704171; 3) Molecule: the relationships between components within communities and NSC 704171; 4) MDR: the compounds that were significantly associated with the NSC 704171.

NSC Compound Enrichment Correlation
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.00896740831404562 0.63114134
NSC 200692 Aspiculamycin hydrochloride 0.00896740831404562 -0.25632298
NSC 368697 Benz[a]anthracene-1,7,12(12b-H)-trione, 2,3,4,4a-tetra- hydro-2,3,4a,8,12a-pentahydroxy-3-methyl- 0.00896740831404562 0.73894808
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.00896740831404562 0.42068964
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.00896740831404562 0.75221049
NSC 651590 ANTINEOPLASTIC-651590 0.00896740831404562 0.62101267
NSC 654893 Null 0.00896740831404562 0.70685503
NSC 657446 Thiazolo[2,3-b]thiazolium, 2,3-dihydro- 2-[(2-methoxyphenyl)methylene]- 5-(3-nitrophenyl)-3-oxo-, chloride 0.00896740831404562 0.60612001
NSC 666388 Null 0.00896740831404562 0.50453413
NSC 5355 Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate (2:1) (9CI) 0.00910228844192553 -0.12951935
Total:135  Current:51    [First] [Prev] [Next] [Last]